TransMedics (TMDX) Other financing activities (2019 - 2025)
TransMedics' quarterly Other financing activities came in at $138000.0 in Q3 2025, down 62.3% quarter-over-quarter from $366000.0 in Q3 2020.
TransMedics has reported Other financing activities for 3 years, with the latest figure at $138000.0 in Q3 2025.
- For the quarter ending Q3 2025, Other financing activities changed N/A year-over-year to $138000.0; the trailing twelve-month figure through Sep 2025 stood at $723000.0 (changed N/A YoY), and the FY2020 full-year result was $705000.0, down 85.45% from the prior year.
- Other financing activities for Q3 2025 stood at $138000.0, down from $366000.0 in the prior quarter.
- The five-year high for Other financing activities was $138000.0 in Q3 2025, with the low at $138000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | TransMedics | 2.32 Bn | 1.86 Bn | 101.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 138,000.00 |
| Sep 30, 2025 | 138,000.00 |
| Sep 30, 2020 | 366,000.00 |
| Sep 30, 2020 | 366,000.00 |
| Jun 30, 2020 | 219,000.00 |
| Jun 30, 2020 | 219,000.00 |
| Mar 31, 2020 | 120,000.00 |
| Mar 31, 2020 | 120,000.00 |
| Dec 28, 2019 | 340,000.00 |
| Dec 28, 2019 | 340,000.00 |
| Sep 28, 2019 | 2.53 Mn |
| Sep 28, 2019 | 2.53 Mn |
| Jun 29, 2019 | 1.28 Mn |
| Jun 29, 2019 | 1.28 Mn |
| Mar 30, 2019 | 705,000.00 |
| Mar 30, 2019 | 705,000.00 |